Log in
NASDAQ:PTCT

PTC Therapeutics Short Interest Ratio and Short Volume

$51.51
-0.58 (-1.11 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$51.29
Now: $51.51
$52.99
50-Day Range
$45.41
MA: $48.91
$54.60
52-Week Range
$30.79
Now: $51.51
$59.89
Volume181,455 shs
Average Volume773,485 shs
Market Capitalization$3.49 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.17

Short Interest

PTC Therapeutics (NASDAQ:PTCT) Short Interest Data

Current Short Volume:5,170,000 shares
Previous Short Volume:4,960,000 shares
Change Vs. Previous Month:+4.23%
Dollar Volume Sold Short:$282.28 million
Short Interest Ratio / Days to Cover:8.0
Last Record Date:September, 30 2020
Outstanding Shares:58,430,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:181,455 shares
Average Trading Volume:773,485 shares
Today's Volume Vs. Average:-76.54%



PTC Therapeutics (NASDAQ:PTCT) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/30/20205,170,000 $282.28 million 4.2%0.0%7.5$54.60
9/15/20204,960,000 $231.14 million -13.0%0.0%6.7$46.60
8/31/20205,700,000 $263.34 million -9.4%0.0%7.4$46.20
8/14/20206,290,000 $311.36 million 22.4%0.0%7.9$49.50
7/31/20205,140,000 $258.59 million -6.0%0.0%6.5$50.31
7/15/20205,470,000 $253.43 million 4.2%0.0%7.7$46.33
6/30/20205,250,000 $247.54 million 7.4%0.0%7.6$47.15
6/15/20204,890,000 $253.94 million 11.1%0.0%7$51.93
5/29/20204,400,000 $231.53 million -1.4%0.0%5.4$52.62
5/15/20204,460,000 $226.17 million 10.7%0.0%5.1$50.71
4/30/20204,030,000 $200.01 million -7.4%0.0%4.4$49.63
4/15/20204,350,000 $204.71 million -3.3%0.0%4.5$47.06
3/31/20204,500,000 $238.77 million 11.5%0.0%4.6$53.06
3/13/20204,037,300 $183.41 million 8.0%0.0%3.8$45.43
2/28/20203,740,000 $152.55 million 7.5%0.0%4.6$40.79
2/14/20203,480,000 $178.70 million 0.9%0.0%4.3$51.35
1/31/20203,450,000 $187.47 million 3.0%0.0%4.4$54.34
1/15/20203,350,000 $188.07 million -4.0%0.0%4.4$56.14
12/31/20193,490,000 $181.20 million 10.1%0.0%4.9$51.92

PTC Therapeutics (NASDAQ:PTCT) Short Interest FAQ

speech bubbles
speech bubbles











What is PTC Therapeutics' current short interest?

Short interest is the volume of PTC Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 5,170,000 shares of PTCT short. 0.00% of PTC Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for PTC Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTC Therapeutics currently has a short interest ratio of 8.0.

Is PTC Therapeutics' short interest increasing or decreasing?

PTC Therapeutics saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 5,170,000 shares, an increase of 4.2% from the previous total of 4,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does PTC Therapeutics' short interest compare to its competitors?

0.00% of PTC Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to PTC Therapeutics: GRIFOLS S A/S (2.43%), Elanco Animal Health (0.00%), Myokardia Inc (0.00%), Dr. Reddy's Laboratories Limited (0.00%), Sarepta Therapeutics Inc (0.00%), Galapagos NV (0.00%), Mirati Therapeutics, Inc. (0.00%), Ascendis Pharma A/S (4.18%), Jazz Pharmaceuticals PLC (8.91%), and Mylan (8.77%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.12 billion), Aon PLC ($3.76 billion), Clorox Co ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), Kroger Co ($2.20 billion), and Simon Property Group Inc ($1.88 billion). View all of the most shorted stocks.

What does it mean to sell short PTC Therapeutics stock?

Short selling PTCT is an investing strategy that aims to generate trading profit from PTC Therapeutics as its price is falling. PTC Therapeutics' stock is trading down $0.58 today. To short PTC Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that PTC Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against PTC Therapeutics?

A short squeeze for PTC Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTCT, which in turn drives the price of the stock up even further.

How often is PTC Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTCT, twice per month. The most recent reporting period available is September, 30 2020.


This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.